Uac.Bk
UAC.BK operates in the Commodity Chemicals industry, producing and distributing chemical products, primarily generating revenue through the sale of chemical goods and related services.
Business. United Acquisition Corp. I (UAC) is a multiline insurance and broker company operating within the insurance industry. The firm is listed on the New York Stock Exchange under the ticker symbol UAC. Specific details regarding its operating segments, headquarters location, and geographic presence are not available in the provided data. Consequently, the company is described at the industry level as a participant in the financials sector focused on insurance activities.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
United Acquisition Corp. I (UAC) is a multiline insurance and broker company operating within the insurance industry. The firm is listed on the New York Stock Exchange under the ticker symbol UAC. Specific details regarding its operating segments, headquarters location, and geographic presence are not available in the provided data. Consequently, the company is described at the industry level as a participant in the financials sector focused on insurance activities.
UAC.BK has a debt-to-equity ratio of 0.27, indicating a relatively conservative capital structure with a strong equity base. The company's liquidity is assessed as medium, with a current ratio of 1.94, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's free cash flow is negative at -74.76 million THB, and its operating cash flow is 327.80 million THB, indicating that capital expenditures are consuming a significant portion of operating cash.
In terms of profitability, UAC.BK's return on equity (ROE) is 4.42%, and its return on assets (ROA) is 2.43%. These figures are below the typical thresholds for strong performance in the Commodity Chemicals industry, suggesting that the company is not generating returns at a level that would be considered robust relative to its peers.
The company's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no material geographic diversification provided in the available data. This lack of diversification could expose the company to higher operational and market risks if demand in its primary market fluctuates.
Looking ahead, UAC.BK's revenue is projected to grow in the current fiscal year, with a positive outlook for the next fiscal year as well. However, the exact numeric deltas for these projections are not provided in the available data. The company's capital expenditure of -49.75 million THB indicates ongoing investment in its operations, which could support future growth.
The company's risk profile includes a medium liquidity risk, primarily due to its negative net cash position after accounting for total debt. While the dilution risk is assessed as low, the company's capital structure and financial flexibility should be monitored for any changes that could affect shareholder value.
Recent events, including filings and transcripts, are not detailed in the available data. However, the company's financial performance and strategic direction can be further analyzed through its disclosed financial statements and any upcoming investor communications.
- UAC.BK maintains a conservative capital structure with a debt-to-equity ratio of 0.27.
- The company's ROE of 4.42% and ROA of 2.43% indicate below-average profitability for the Commodity Chemicals industry.
- UAC.BK's revenue is concentrated in a single business segment, with no significant geographic diversification.
- The company's liquidity is assessed as medium, with a current ratio of 1.94.
- UAC.BK's free cash flow is negative, indicating that capital expenditures are consuming a significant portion of operating cash.
- The company's dilution risk is low, but its liquidity risk remains a concern due to its negative net cash position.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- UAC.BK Market data — financials · 2026-05-29
Ownership & reference
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Debt-to-equity (FY 2025-12-31): -15.72xDerived (calculated)
- Current ratio (FY 2025-12-31): 0.08xDerived (calculated)
- Shareholders' equity (annual): USD -24.5KSEC XBRL filing
- Current assets (annual): USD 30.56KSEC XBRL filing
- Total assets (annual): USD 360.67KSEC XBRL filing
- Total liabilities (annual): USD 385.17KSEC XBRL filing
- Current liabilities (annual): USD 385.17KSEC XBRL filing